Champions Oncology (CSBR) Net Cash Flow (2010 - 2026)

Champions Oncology has reported Net Cash Flow for 17 years, with the latest figure at -$2.3 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 134.25% year-over-year to -$2.3 million in Q2 2026; TTM through Apr 2026 was -$4.9 million, a 168.55% decrease from a year earlier, with the FY2026 full-year figure at -$4.9 million, down 168.55% from the prior year.
• Net Cash Flow was -$2.3 million for Q2 2026 at Champions Oncology, down from -$1.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $6.6 million in Q2 2025, with the low at -$5.2 million in Q3 2023.
• Average Net Cash Flow over 5 years is $5055.6, with a median of $68000.0 recorded in 2024.
• The largest YoY upside for Net Cash Flow was 455.84% in 2025 against a maximum downside of 1210.87% in 2025.
• Over 5 years, Net Cash Flow stood at $2.8 million in 2022, then plunged by 76.73% to $644000.0 in 2023, then plunged by 121.43% to -$138000.0 in 2024, then sank by 1210.87% to -$1.8 million in 2025, then fell by 24.65% to -$2.3 million in 2026.
• The last three Net Cash Flow figures came in at -$2.3 million (Q2 2026), -$1.4 million (Q1 2026), and -$1.8 million (Q4 2025), per Business Quant data.